The firm said that its shares will begin trading on the OTCQB exchange starting on Feb. 22.
The assay has been available outside the US since November and runs on the Liaison MDX benchtop instrument.
The test kit runs on standard qPCR platforms in under three hours, and detects 20 cancer-associated biomarkers from four oncogenes.
Recently validated on pseudomonas and TB samples, the business card-sized device also enables on-chip extraction.
The test analyzes the mitochondrial genome to determine which men with clinical suspicion of prostate cancer are likely to have high-grade disease.
In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.
Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.
Researchers are using gene editing to develop more robust livestock and crops, AFP reports.
Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.
This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.
This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.